The cardiovascular risk management for people living with HIV in Europe: How well are we doing?

AIDS

Volumn 30, Issue 16, 2016, Pages 2505-2518

  Shahmanesh, Maryam ^a   Schultze, Anna ^a   Burns, Fiona ^a   Kirk, Ole ^b   Lundgren, Jens ^b   Mussini, Cristina ^d   Pedersen, Court ^e   De Wit, Stephane ^f   Kutsyna, Galyna ^c   Mocroft, Amanda ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^f Lugansk State Medical University   (Ukraine)

Author keywords

Antiretoviral therapy; Cardiovascular risk; Cohort; Europe; HIV

Indexed keywords

CD4 ANTIGEN; CHOLESTEROL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; EUROPE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OBESITY; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SMOKING; CARDIOVASCULAR DISEASE; COMPLICATION; HEALTH SERVICES RESEARCH; MIDDLE AGED; PROCEDURES; RISK MANAGEMENT;

ADULT; CARDIOVASCULAR DISEASES; EUROPE; FEMALE; HEALTH SERVICES RESEARCH; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK MANAGEMENT;

EID: 84979695808     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000001207     Document Type: Article

References (22)

1. Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe: epidemiological update. European Heart Journal 2013; 34:3028-3034.
2. Lodwick RK, Sabin CA, Porter K, Ledergerber B, van SA, Cozzi-Lepri A, et al. Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study. Lancet 2010; 376:340-345.
3. Ray M, Logan R, Sterne JA, Hernandez-Diaz S, Robins JM, Sabin C, et al. The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS 2010; 24:123-137.
4. Havlik RJ, Brennan M, Karpiak SE. Comorbidities and depression in older adults with HIV. Sex Health 2011; 8:551-559.
5. Brent RJ, Brennan M, Karpiak SE. Economic evaluations of HIV prevention in rich countries and the need to focus on the aging of the HIV-positive population. Curr Opin HIV AIDS 2010; 5:255-260.
6. Worm SW, Sabin C, Weber R, Reiss P, El-Sadr W, Dabis F, et al. Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study. J Infect Dis 2010; 201:318-330.
7. De WS, Sabin CA, Weber R, Worm SW, Reiss P, Cazanave C, et al. Incidence and risk factors for new-onset diabetes in HIVinfected patients: the data collection on adverse events of anti-HIV drugs (D:A:D) study. Diabetes Care 2008; 31:1224-1229.
8. Sabin CA, Worm SW, Weber R, Reiss P, El-Sadr W, Dabis F, et al. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multicohort collaboration. Lancet 2008; 371:1417-1426.
9. Worm SW, Friis-Moller N, Bruyand M, D'Arminio MA, Rickenbach M, Reiss P, et al. High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome. AIDS 2010; 24:427-435.
10. Beaglehole R, Epping-Jordan J, Patel V, Chopra M, Ebrahim S, Kidd M, et al. Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary healthcare. Lancet 2008; 372:940-949.
11. Van OJ, Ku GM, Bermejo R, Kegels G, Hermann K, Van DW. The growing caseload of chronic life-long conditions calls for a move towards full self-management in low-income countries. Global Health 2011; 7:38.
12. Allotey P, Reidpath DD, Yasin S, Chan CK, de-Graft AA. Rethinking health-care systems: a focus on chronicity. Lancet 2011; 377:450-451.
13. Seddon ME, Marshall MN, Campbell SM, Roland MO. Systematic review of studies of quality of clinical care in general practice in the UK, Australia and New Zealand. Qual Healthcare 2001; 10:152-158.
14. Bodenheimer T, Chen E, Bennett HD. Confronting the growing burden of chronic disease: can the U.S. healthcare workforce do the job? Health Aff (Millwood) 2009; 28:64-74.
15. Mocroft A, Phillips AN, Gatell J, Horban A, Ledergerber B, Zilmer K, et al. CD4 counts and viral load-specific rates of AIDS, non-AIDS and deaths according to current antiretroviral use. AIDS 2013; 27:907-918.
16. Friis-Moller N, Thiebaut R, Reiss P, Weber R, Monforte AD, De WS, et al. Predicting the risk of cardiovascular disease in HIVinfected patients: the data collection on adverse effects of anti-HIVdrugs study. Eur JCardiovasc PrevRehabil 2010;17:491-501.
17. Sabin CA, D'Arminio MA, Friis-Moller N, Weber R, El-Sadr WM, Reiss P, et al. Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction. Clin Infect Dis 2008; 46:1101-1110.
18. Nichols M, Townsend N, Luengo-Fernandez R, Leal J, Gray A, Scarborough P, Rayner M. European cardiovascular disease statistics. Brussels, Sophia Antipolis: European Heart Network, European Society of Cardiology; 2012, www://ad.ucl.ac.uk/slms/home1/rehqmsh/Downloads/European%20cardiovascular %20disease%20statistics%202012.pdf [accessed 30 July 2014].
19. European Centre for Disease Prevention and Control/WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 2012. Stockholm: European Centre for Disease Prevention and Control; 2013, http://www.euro.who.int/-data/assets/pdf-file/0018/235440/e96953.pdf?ua=1 [accessed 30 July 2014].
20. Rasmussen LD, Helleberg M, May M, Afzal S, Kronborg G, Larsen CS, et al. Myocardial infarction among Danish HIV infected individuals: population attributable fraction associated with smoking. Clin Infect Dis 2015:p.civ013.
21. Sanchez RG, Cuixart CB, Carcia JM, Taomilehto J, Ryden L. Euroheart II project evaluation of diabetes guidelines for cardiac patients Work package 9. 2013. http://www.escardio.org/sta tic-file/Escardio/EU-Affairs/euroheart-2-wp9.pdf [accessed 4 August 2014].
22. Caulfield M, MacDonald T, Brady A, McCormack T, Poulter N, MacGregor G. Letter to DoH and NICE regarding hypertension targets in the Quality Outcomes Framework. Leicester, UK: British Hypertension Society; 2014, http://www.bhsoc.org/files/5813/9118/2189/BHS-BP UK-QOF-Hypertension-Targets-Jan-14.pdf [accessed 1 August 2014].